AWA
WST icon

Arkadios Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Arkadios Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$664K Sell
1,849
-65
-3% -$19.9K 0.01% 976
2026
Q1 		$480K Sell
1,914
-215
-10% -$53.5K 0.01% 1129
2025
Q4 		$586K Sell
2,129
-105
-5% -$28.7K 0.01% 926
2025
Q3 		$586K Buy
2,234
+969
+77% +$236K 0.01% 867
2025
Q2 		$277K Buy
1,265
+10
+0.8% +$2.14K 0.01% 1085
2025
Q1 		$281K Sell
1,255
-9
-0.7% -$2.48K 0.01% 931
2024
Q4 		$414K Buy
1,264
+66
+6% +$20.8K 0.02% 623
2024
Q3 		$360K Buy
1,198
+211
+21% +$64.6K 0.02% 649
2024
Q2 		$325K Buy
987
+8
+0.8% +$2.83K 0.02% 610
2024
Q1 		$388K Sell
979
-8
-0.8% -$2.96K 0.03% 459
2023
Q4 		$348K Sell
987
-258
-21% -$91.3K 0.03% 472
2023
Q3 		$467K Sell
1,245
-48
-4% -$18.6K 0.04% 352
2023
Q2 		$494K Sell
1,293
-112
-8% -$40K 0.06% 311
2023
Q1 		$487K Buy
1,405
+228
+19% +$66.6K 0.06% 310
2022
Q4 		$277K Sell
1,177
-212
-15% -$50.2K 0.04% 430
2022
Q3 		$342K Buy
1,389
+104
+8% +$31.7K 0.05% 343
2022
Q2 		$389K Buy
1,285
+335
+35% +$109K 0.06% 338
2022
Q1 		$390K Sell
950
-575
-38% -$225K 0.05% 364
2021
Q4 		$715K Sell
1,525
-363
-19% -$156K 0.09% 251
2021
Q3 		$801K Sell
1,888
-855
-31% -$360K 0.12% 201
2021
Q2 		$985K Buy
2,743
+2,643
+2,643% +$873K 0.12% 203
2021
Q1 		$28K Hold
100
– – ﹤0.01% 876
2020
Q4 		$28K Buy
+100
New +$28.1K 0.01% 675

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Arkadios Wealth Advisors's WST Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its West Pharmaceutical (WST) stake by 3.4% in Q2 2026, selling an estimated $19.9K and leaving 1,849 shares worth $664K. The position accounts for 0.01% of the portfolio, ranked #976.

Arkadios Wealth Advisors first reported a position in WST in Q4 2020 and has held it in 23 quarters since. The position peaked at $985K in Q2 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Arkadios Wealth Advisors held 1,849 shares of West Pharmaceutical worth $664K as of Q2 2026.
  • Arkadios Wealth Advisors sold 65 West Pharmaceutical shares in Q2 2026, an estimated $19.9K.
  • West Pharmaceutical made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #976 holding.
  • Arkadios Wealth Advisors first reported a position in West Pharmaceutical in Q4 2020 and has held it in 23 quarters since.
  • Arkadios Wealth Advisors's West Pharmaceutical position peaked at $985K in Q2 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.